VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Sacituzumab Tirumotecan (Sac-TMT) Sets New Survival Standard in Heavily Pretreated EGFR-Mutant NSCLC: Final OS Results from OptiTROP-Lung03
Sacituzumab Tirumotecan (Sac-TMT) Sets New Survival Standard in Heavily Pretreated EGFR-Mutant NSCLC: Final OS Results from OptiTROP-Lung03
May 22, 2026 00:00 CST Updated 01:52
Share:
